WHO WE ARE

Developed Through Years of Clinical Research.

Under the direction of molecular biologist Dr. Sigridur Jakobsdóttir, LIGHT GLP-1™ has undergone multiple clinical trials to validate its impact on appetite, metabolism, and weight-loss. Today, it’s trusted by hundreds of weight loss clinicians across the U.S. in patient care.

  • 9 lbs

    90 day weight loss

    Compared to just 2.5
    lbs in the placebo group

  • 600 cal

    Reduced daily

    Lowered calorie intake,
    due to feeling fuller faster

  • 76%

    Increase in GLP-1

    The hunger hormone
    that reduces cravings

  • 8 inches

    Waist reduction

    Loss of visceral fat,
    without loss of muscle

     

CLINICAL STUDIES

Real Science. Real Results.

Weight loss, improved body metrics, and a better blood lipid profile:

https://www.nature.com/articles/s41598-019-39159-5

Reductions in body weight, BMI, and central fat mass, independent of physical activity:
Marhuenda J et al (2020). Foods 9(1), 55
Decrease in appetite sensation, and reduced calorie intake following an ad-libitum meal.
Serna A et al (2021). Eur J Nutr. 2021 Sep 30

Improvements in body measurements and Increased levels of anorexigenic hormones (GLP-1)
Boix-Castejón M et al (2018). Food Func. 9(6):3173:3184